Identification of new drug targets in Mycobacterium avium and Mycobacterium tuberculosis

Research in Microbiology

Volumn 147, Issue 1-2, 1996, Pages 97-105

  Rastogi, N ^a,c   Goh, K S ^a   Van Ginkel, S Z ^b   Wright, E L ^b   Barrow, W W ^b  

^a Unite de la Tuberculose et des Mycobacteries   (Guadeloupe)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

^c Institut Pasteur de Guadeloupe   (Guadeloupe)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CERULENIN; CINNAMIC ACID; CLOFAZIMINE; ETHAMBUTOL; ISONIAZID; OFLOXACIN; RIFAMPICIN;

ANTIMICROBIAL ACTIVITY; CONFERENCE PAPER; DRUG ACTIVITY; DRUG TARGETING; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

EID: 0029878145     PISSN: 09232508     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2508(96)80210-5     Document Type: Conference Paper

References (36)

1. Arbeit, R.D., Slutsky, A., Barber, T.W., Maslow, J.N., Niemczyk, S., Falkinham, J.O., III, O'Connor, G.T. & vonReyn, C.F. (1993), Genetic diversity among strains of Mycobacterium avium causing monoclonal and polyclonal bacteremia in patients with AIDS. J. Infect. Dis., 167, 1384-1390.
2. Barnes, P.F., Le, H.Q. & Davidson, P.T. (1993), Tuberculosis in patients with HIV infection. Med. Clin. North Am., 77, 1369-1390.
3. Barrow, W.W. (1991), Contributing factors of pathogenesis in the Mycobacterium avium complex. Res. Microbiol., 142, 427-433.
4. Barrow, W.W., Wright, E.L., Goh, K.S. & Rastogi, N. (1993), Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium. Antimicrob. Agents Chemother., 37, 652-661.
5. Belisle, J.T., McNeil, M.R., Chatterjee, D., Inamine, J.M. & Brennan, P.J. (1993), Expression of the core lipopeptide of the glycopeptidolipid surface antigens in rough mutants of Mycobacterium avium. J. Biol. Chem., 268, 10510-10516.
6. David, H.L. (1970), Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl. Microbiol., 20, 810-814.
7. David, H.L., Rastogi, N., Clavel-Seres, S. & Clement, F. (1988), Alterations in the outer wall architecture caused by the inhibition of mycoside C biosynthesis in Mycobacterium avium. Curr. Microbiol., 17, 61-68.
8. Ellner, J.J. (1990), Tuberculosis in the time of AIDS, in "The facts and the message". Chest, 98, 1051-1052.
9. Ellner, J.J., Goldberger, M.J. & Parenti, D.M. (1991), Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution. J. Infect. Dis., 163, 1326-1335.
10. Gangadharam, P.R.J. (1993), Drug resistance in tuberculosis, in "Tuberculosis. A Comprehensive International Approach" (Reichman, L.B., and E.S. Hershfield, ed.) (293-328). Marcel Dekker, Inc., New York, NY.
11. Heifets, L.B. (1991), Dilemmas and realities in drug susceptibility testing of M. avium and M. intracellulare and other slowly growing nontuberculosis mycobacteria, in "Drug Susceptibility in the Chemotherapy of Mycobacterial Infections" (Heifets, L.B.) (123-141). CRC Press, Boca Raton, FL.
12. Hoffner, S.E., Kratz, M., Olsson-Liljequist, B., Svenson, S.B. & Källenius, G. (1989), In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex. J. Antimicrob. Chemother., 24, 317-324.
13. 1 layer of Mycobacterium intracellulare serovar 20. Infect. Immun., 54, 133-141.
14. Ji, B., Lounis, N., Truffot-Pernot, C. & Grosset, J. (1994), Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model. Antimicrob. Agents Chemother., 38, 2521-2529.
15. Klopman, G., Wang, S., Jacobs, M.R., Bajaksouzian, S., Edmonds, K. & Ellner, J.J. (1993), Anti-Mycobacterium avium activity of quinolones : in vitro activities. Antimicrob. Agents Chemother., 37, 1799-1806.
16. Klopman, G., Wang, S., Jacobs, M.R. & Ellner, J.J. (1993), Anti-Mycobacterium avium activity of quinolones: structure-activity relationship studies. Antimicrob. Agents Chemother., 37, 1807-1815.
17. Neville, K., Bromberg, A., Bromberg, R., Bonk, S., Hanna, B.A. & Rom, W.N. (1994), The third epidemic: multidrug-resistant tuberculosis. Chest, 105, 45-48.
18. Nomura, S., Horiuchi, T., Omura, S. & Hata, T. (1972), The action mechanism of cerulenin. J. Biochem. (Tokyo), 71, 783-786.
19. Omura, S. (1976), The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. Bacteriol. Rev., 40, 681-697.
20. Perrone, C., Gikas, A., Truffot-Pernot, C., Grosset, J., Pocidalo, J.J. & Vilde, J.L. (1991), Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. Antimicrob. Agents Chemother., 35, 1356-1359.
21. Ramasesh, N., Wright, E.L., Woodbury, J.L. & Barrow, W.W. (1990), Biosynthesis of the serovar-specific glycopeptidolipid antigens associated with the L1 layer of the Mycobacterium avium complex. First International Conference on the Pathogenesis of Mycobacterial Infections, Stockholm, Sweden.
22. Rastogi, N., Fréhel, C., Ryter, A., Ohayon, H., Lesourd, M. & David, H.L. (1981), Multiple drug-resistance in Mycobacterium avium: is the cell wall architecture responsible for the exclusion of antimicrobial agents ? Antimicrob. Agents Chemother., 20, 666-677.
23. Rastogi, N., Goh, K.S. & David, H.L. (1990), Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis. Antimicrob. Agents Chemother., 34, 759-764.
24. Rastogi, N., Goh, K.S., Wright, E.L. & Barrow, W.W. (1994), Potential drug targets for Mycobacterium avium defined by using radiometric drug-inhibitor combination techniques. Antimicrob. Agents Chemother., 38, 2287-2295.
25. Ryan, F. (1992), The Forgotten Plague. Little, Brown and Company, Boston.
26. Sepkowitz, K.A. & Raffalli, J. (1994), Tuberculosis at the end of the twentieth century. Eur. J. Clin. Microbiol. Infect. Dis., 13, 902-907.
27. Siddiqi, S.H., Libonati, J.P. & Middlebrook, G. (1981), Evaluation of a rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol., 13, 908-913.
28. Slutsky, A.M., Arbeit, R.D., Barber, T.W., Rich, J., von-Reyn, C.F., Pieciak, W., Barlow, M.A. & Maslow, J.N. (1994), Polyclonal infections due to Mycobacterium avium complex in patients with AIDS detected by pulsed-field gel electrophoresis of sequential clinical isolates. J. Clin. Microbiol., 32, 1773-1778.
29. Suzuki, A.E. & Inamine, J.M. (1994), Genetic aspects of drug resistance in Mycobacterium avium. Res. Microbiol., 145, 210-213.
30. Telenti, A., Imboden, P., Marchesi, F., Lowrie, D., Cole, S., Colston, M.J., Matter, L., Schopfer, K. & Bodner, T. (1993), Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet, 341, 647-650.
31. von Reyn, C.F., Jacobs, N.J., Arbeit, R.D., Maslow, J.N. & Niemczyk, S. (1995), Polyclonal Mycobacterium avium infections in patients with AIDS: variations in antimicrobial susceptibilities of different strains of M. avium isolated from the same patient. J. Clin. Microbiol., 33, 1008-1010.
32. Williams, D.L., Waguespack, C., Eisenach, K., Crawford, J.T., Portaels, F., Salfinger, M., Nolan, C.M., Abe, C., Sticht-Groh, V. & Gillis, T.P. (1994), Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother., 38, 2380-2386.
33. Woodbury, J.L. & Barrow, W.W. (1989), Radiolabelling of Mycobacterium avium oligosaccharide determinant and use in macrophage studies. J. Gen. Microbiol., 135, 1875-1884.
34. Wright, E.L. & Barrow, W.W. (1991), Inhibition of glycopeptidolipid synthesis resulting from treatment of Mycobacterium avium with 2-deoxy-D-glucose. Res. Microbiol., 142, 597-608.
35. Wright, E.L., Richmond, M.G. & Barrow, W.W. (1990), Accumulation of apolar glycopeptidolipid resulting from cycloserine inhibition of polar glycopeptidolipids in Mycobacterium avium. Infect. Immun. (Life Sci. Adv.), 9, 47-54.
36. Zhang, Y., Heym, B., Allen, B., Young, D. & Cole, S. (1992), The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature (Lond.), 358, 591-593.